Categories: Business

Jim Cramer says the ‘Ark Make investments phenomenon’ seems to be over for now

CNBC’s Jim Cramer said Friday that Ark Invest’s stock-moving influence appears to be waning — at least for now.

Ark Invest’s family of exchange-traded funds were some of the best performers on Wall Street last year, but have not fared well in 2021 as investors rotated away from high-growth stocks and into economic recovery plays.

The “Mad Money” host said as the funds run by star money manager Cathie Wood’s firm struggled, the amount of outflows started to pick up. That has implications for the stocks that are components of the ETFs, Cramer said.

“It seems pretty clear that the Ark Invest phenomenon is no longer in play,” Cramer said. “We’re not seeing major outflows here, but the era of Cathie Wood propping these stocks up with her own buying bazooka, I think, it appears to be over.”

The opposite was true last year as investors started to notice how well Wood’s family of funds was performing, Cramer said, leading the firm to see a massive wave of inflows and new firepower to deploy into the market.

Cramer noted that Ark’s flagship ARK Innovation ETF have started to perform better recently as growth stocks returned to favor. Indeed, the fund is up about 2.4% over the past 5 days, while the S&P 500, by comparison, is down 1.9%.

ARK Innovation also rose 6% between June 7 and June 11.

“Here’s the bottom line: when you look at the fund flows, Ark Invest’s no longer propping up the turbo-charged growth stocks, which makes their recent rebound feel a lot more significant to me,” Cramer said.

“Maybe if this group keeps climbing, Cathie Wood can get her bazooka back, but until then the ‘WoodStocks’ will rise or fall on their own.”

Jimmy Page

MV Telegraph Writer Jimmy Page has been writing for all these 37 years.

Recent Posts

Why Multifamily Properties Are a Smart Play for Real Estate Investors in 2026

Picture this: a bustling apartment complex filled with tenants who reliably pay rent every month.…

2 months ago

Metformin for Longevity: Understanding Its Anti-Aging Potential

Metformin has been used for decades. Not as a wellness trend. Not as a supplement…

2 months ago

Ashton Kutcher returns to appearing in The Magnificence

Ashton Kutcher does not bother anyone with this beauty treatment. At least the company doesn't.…

2 months ago

First GLP-1 anti-obesity capsule from Novo Nordisk launches within the US

The logo of pharmaceutical company Novo Nordisk is seen outside its offices in Bagsvaerd on…

2 months ago

The petty and infantile purpose Trump will not permit Machado to steer Venezuela

Donald Trump is by far the pettiest president in US history. He never forgets an…

2 months ago

Protection Shares Rise; The US assault on Venezuela heralds the period of “laborious energy”.

Defense stocks in Europe and Asia rose sharply on Monday as investors gauged that the…

2 months ago

This website uses cookies.